Targeting CD38 Enzymatic Function in Antibody-Driven Immunotherapy for Multiple Myeloma: Insights from Basic Research - Poll - MDSpire

Targeting CD38 Enzymatic Function in Antibody-Driven Immunotherapy for Multiple Myeloma: Insights from Basic Research

  • By

  • Alberto L. Horenstein

  • Kristine A. Frerichs

  • Angelo C. Faini

  • Niels W. C. J. van de Donk

  • Fabio Malavasi

  • April 29, 2026

  • 0 min

Share

Original Source(s)

Targeting CD38 Enzymatic Function in Antibody-Driven Immunotherapy for Multiple Myeloma: Insights from Basic Research

  • by Alberto L. Horenstein, Kristine A. Frerichs, Angelo C. Faini, Niels W. C. J. van de Donk, Fabio Malavasi

  • April 29, 2026

Related Content

A propensity score matching study on clinical characteristics and risk factors of herpes zoster in malignant tumor

This Week’s CGT News: Lilly’s $7B In Vivo CAR-T Bet

Lilly moves to acquire Kelonia, plus gene therapy for deafness approved

  • April 27, 2026

  • 6 min
Case Report: Cytoreductive surgery as a therapeutic attempt in the treatment of extramedullary plasmacytoma